CILOSTAMIDE
CILOSTAMIDE Basic information
- Product Name:
- CILOSTAMIDE
- Synonyms:
-
- OPC 3689
- OCP 3689
- N-CYCLOHEXYL-N-METHYL-4-(1,2-DIHYDRO-2-OXO-6-QUINOLYLOXY)BUTYRAMIDE
- CILOSTAMIDE
- Cilostamide,OPC 3689
- ciloalaMide
- 6-[3-(N-Cyclohexyl-N-methylcarbamoyl)propoxy]quinolin-2[1H]-one
- N-cyclohexyl-4-[(2-hydroxyquinolin-6-yl)oxy]-N-methylbutanamide
- CAS:
- 68550-75-4
- MF:
- C20H26N2O3
- MW:
- 342.43
- Product Categories:
-
- Cyclic Nucleotide related
- Mol File:
- 68550-75-4.mol
CILOSTAMIDE Chemical Properties
- Melting point:
- 186~188℃
- Boiling point:
- 594.3±50.0 °C(Predicted)
- Density
- 1.18±0.1 g/cm3(Predicted)
- storage temp.
- 0-6°C
- solubility
- Soluble in DMSO (up to 30 mg/ml).
- form
- White solid
- pka
- 11.12±0.70(Predicted)
- color
- White
- Stability:
- Stable for 1 year from date of purchase as supplied. Solutions in DMSO may be stored at -20° for up to 3 months.
CILOSTAMIDE Usage And Synthesis
Description
Cilostamide (68550-75-4) is a selective inhibitor of phosphodiesterase-3 (PDE3). Displays limited selectivity for PDE3A versus PDE3B (IC50 = 27 and 50 nM).1,2 Blocks PKB/Akt signaling pathway downstream via inhibition of Akt-activated PDE3B.3 Cilostamide reverses the effect of leptin on food intake and body weight.4
Uses
Serotonin receptor ligand
Uses
Cilostamide (OPC 3689) is a specific phosphodiesterase 3 (PDE3) inhibitor.
Definition
ChEBI: N-cyclohexyl-N-methyl-4-[(2-oxo-1H-quinolin-6-yl)oxy]butanamide is a member of quinolines.
Biological Activity
Selective inhibitor of type III phosphodiesterase (PDE3). Displays moderate selectivity for PDE3A isozyme vs. PDE3B (IC 50 values are 0.027 and 0.050 μ M for PDE3A and PDE3B respectively). Inhibits ADP-induced platelet aggregation (IC 50 = 16.8 μ M); anti-thrombotic. Also available as part of the Phosphodiesterase Inhibitor Tocriset™ .
Biochem/physiol Actions
Selective inhibitor of PDE3 (cGMP-inhibited phosphodiesterase); IC50 = 70 ± 9 nM. This inhibitory effect increases intracellular cAMP and inhibits platelet aggregation.
storage
Store at RT
References
[1] H HIDAKA. Selective inhibitor of platelet cyclic adenosine monophosphate phosphodiesterase, cilostamide, inhibits platelet aggregation.[J]. Journal of Pharmacology and Experimental Therapeutics, 1979, 211 1: 26-30.
[2] S. CHRISTENSEN T T. Chapter 19. Isozyme-Selective Phosphodiesterase Inhibitors as Antiasthmatic Agents[J]. Annual Reports in Medicinal Chemistry, 1994, 29 1: 185-194. DOI:10.1016/s0065-7743(08)60732-0
[3] F AHMAD. Cyclic nucleotide phosphodiesterase 3B is a downstream target of protein kinase B and may be involved in regulation of effects of protein kinase B on thymidine incorporation in FDCP2 cells.[J]. Journal of immunology, 2000, 164 9: 4678-4688. DOI:10.4049/jimmunol.164.9.4678
[4] ALLAN Z. ZHAO. A phosphatidylinositol 3-kinase–phosphodiesterase 3B–cyclic AMP pathway in hypothalamic action of leptin on feeding[J]. Nature neuroscience, 2002, 5 8: 727-728. DOI:10.1038/nn885
CILOSTAMIDESupplier
- Tel
- 821-50328103-801 18930552037
- 3bsc@sina.com
- Tel
- 027-86697669 13986148687
- sales@tcaschem.com
- Tel
- 025-66113011 17798518460
- cfzhang@aikonchem.com
- Tel
- 13816107857
- sales@fortunechem-sh.com
- Tel
- +1 (866) 930-6790
- info@adooq.com
CILOSTAMIDE(68550-75-4)Related Product Information
- ZARDAVERINE
- RO 20-1724
- Pentoxifylline
- AG 1295
- S- (+)-Rolipram
- ETAZOLATE
- BRL 50481
- Vinpocetine
- ZAPRINAST
- ROLIPRAM
- Cilostazol
- (4S)-4-[3-(CYCLOPENTYLOXY)-4-METHOXYPHENYL]PYRROLIDIN-2-ONE
- EHNA HYDROCHLORIDE
- 4-[[3,4-(METHYLENEDIOXY)BENZYL]AMINO]-6-CHLOROQUINAZOLINE
- CILOSTAMIDE
- 2-Hydroxy-6-methoxyquinoline
- 6-HYDROXYQUINOLINE
- 4-BUTOXYACETANILIDE